Canada Pension Plan Investment Board Has $777.49 Million Position in Johnson & Johnson (NYSE:JNJ)

Canada Pension Plan Investment Board grew its holdings in Johnson & Johnson (NYSE:JNJ) by 55.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,730,681 shares of the company’s stock after purchasing an additional 1,685,664 shares during the quarter. Johnson & Johnson comprises about 1.0% of Canada Pension Plan Investment Board’s portfolio, making the stock its 17th biggest position. Canada Pension Plan Investment Board’s holdings in Johnson & Johnson were worth $777,487,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in JNJ. OLD Mission Capital LLC bought a new stake in Johnson & Johnson during the 3rd quarter worth approximately $362,000. Sage Mountain Advisors LLC bought a new position in shares of Johnson & Johnson in the fourth quarter worth $525,000. Ironwood Wealth Management LLC. increased its holdings in shares of Johnson & Johnson by 1,559.2% in the fourth quarter. Ironwood Wealth Management LLC. now owns 7,400 shares of the company’s stock worth $1,165,000 after purchasing an additional 6,954 shares during the period. Mattern Capital Management LLC increased its stake in Johnson & Johnson by 3.5% in the fourth quarter. Mattern Capital Management LLC now owns 30,032 shares of the company’s stock valued at $4,726,000 after acquiring an additional 1,014 shares during the last quarter. Finally, United Bank increased its stake in Johnson & Johnson by 46.4% in the fourth quarter. United Bank now owns 9,863 shares of the company’s stock valued at $1,552,000 after acquiring an additional 3,127 shares during the last quarter. 66.60% of the stock is currently owned by institutional investors.

Shares of JNJ traded up $0.90 during trading hours on Thursday, reaching $170.39. 305,568 shares of the stock traded hands, compared to its average volume of 6,223,537. The company has a market capitalization of $448.71 billion, a P/E ratio of 30.07, a P/E/G ratio of 2.71 and a beta of 0.71. Johnson & Johnson has a 52-week low of $133.65 and a 52-week high of $173.65. The company’s 50-day simple moving average is $167.25. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.04 and a current ratio of 1.28.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, July 20th. The company reported $2.48 EPS for the quarter, topping the Zacks’ consensus estimate of $2.29 by $0.19. The business had revenue of $23.31 billion for the quarter, compared to the consensus estimate of $22.54 billion. Johnson & Johnson had a net margin of 17.95% and a return on equity of 34.62%. The company’s revenue for the quarter was up 27.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.67 EPS. Equities research analysts expect that Johnson & Johnson will post 9.51 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 7th. Stockholders of record on Tuesday, August 24th will be given a $1.06 dividend. The ex-dividend date of this dividend is Monday, August 23rd. This represents a $4.24 annualized dividend and a dividend yield of 2.49%. Johnson & Johnson’s payout ratio is presently 52.80%.

A number of analysts have recently weighed in on the stock. Credit Suisse Group set a $193.00 target price on shares of Johnson & Johnson and gave the stock a “buy” rating in a report on Monday, June 7th. Morgan Stanley assumed coverage on shares of Johnson & Johnson in a report on Friday, May 28th. They issued an “overweight” rating and a $187.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Johnson & Johnson presently has a consensus rating of “Buy” and an average target price of $190.38.

Johnson & Johnson Company Profile

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.

See Also: Certificate of Deposit (CD)

Want to see what other hedge funds are holding JNJ? Visit to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with's FREE daily email newsletter.